ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Kidney Week 2025: Highlights

Plenaries

ASN offers exciting, dynamic plenaries daily which showcase this extraordinary time in nephrology. The opening plenary on Thursday, November 6 features the ASN President's Address, the state-of-the-art lecture "Yes We Can...Cure Kidney Diseases" by Vlado Perkovic, MBBS, PhD, FASN, two featured high-impact clinical trials, and an expert panel including Julie R. Ingelfinger, MD, and Alan S. Kliger, MD.

On Friday, November 7, the plenary features the state-of-the-art lecture "Systems Biology of Kidney Diseases" by Julio Saez-Rodriguez, PhD, followed by an expert panel including Laura Barisoni, MD, Matthias Kretzler, MD, and Navdeep Tangri, MD, PhD.

On Saturday, November 8, the plenary features TWO state-of-the-art lectures: "On Kidney Medicine, Drug Development, and Coming Home" by Reshma Kewalramani, MD, FASN, and "Resilience at Work and at Home: Finding the Rugged Qualities and Collective Resources We Need" by Michael Ungar, PhD.

The full plenary on Sunday, November 9 is focused on xenotransplantation advances. Xenotransplantation has seen significant advances, driven by the organ shortage crisis and a sustainable alternative to human organ donation. ASN has assembled an expert panel to discuss xenotransplant topics, including surgery and protocols, ethics and selection, translational science, and payment considerations: David K.C. Cooper, MD, PhD, MA, MS; Paul E. Klotman, MD; Rachel Nell Meyer; Robert A. Montgomery, MD, PhD; Leonardo V. Riella, MD, PhD, FASN.

TIME100 Most Influential People 2025

Congratulations to Reshma Kewalramani, MD, FASN, and Robert A. Montgomery, MD, PhD!

Late-Breaking Clinical Trials

ASN welcomes randomized trials (Phase 2, 3, 4) that will have significant impact on clinical practice on all topics touching kidney diseases including AKI, CKD, Diabetes, Dialysis, Genetic Diseases, Glomerular Diseases, Hypertension, Kidney Stones, Pediatrics, Transplantation, and more. The submission period opens on Wednesday, July 16, and closes on Tuesday, September 9, at 2:00 p.m. EDT.

Why submit to Kidney Week?
  • Reach a global audience: More than 12,000 leading nephrologists, researchers, industry professionals, and others attend this largest kidney meeting in the world.
  • Gain immediate recognition: Attract media attention and scientific interest. All main stage podium presentations will be invited to present at a press-embargoed session.
How are clinical trials highlighted at Kidney Week?
  • Two high-impact clinical trials featured in the opening plenary.
  • Multiple late-breaking oral sessions.
  • More presentation time for high-impact research.
  • Increased collaboration with JASN, JAMA, Lancet, and NEJM.

Early Programs on Wednesday, November 5

ASN offers seven full-day early programs on timely nephrology topics. These in-person programs provide smaller settings for more interaction and networking.

Welcome Reception on Thursday, November 6, 6:00-7:00 p.m.

All Kidney Week participants are invited to this reception in the exhibit hall. Join us for food, drinks, and networking.